| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
72,430 |
64,791 |
$16.76M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
44,326 |
40,347 |
$8.95M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24,363 |
22,594 |
$5.89M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14,610 |
13,395 |
$3.66M |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,824 |
9,124 |
$3.36M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,595 |
10,797 |
$2.89M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15,709 |
13,933 |
$1.95M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,382 |
5,000 |
$1.88M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,191 |
2,602 |
$1.56M |
| G0378 |
Hospital observation service, per hour |
13,009 |
5,376 |
$1.06M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,984 |
7,767 |
$904K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,476 |
2,338 |
$820K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,580 |
1,464 |
$744K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,945 |
5,064 |
$628K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,333 |
1,974 |
$571K |
| 97032 |
|
2,825 |
1,094 |
$569K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,287 |
1,804 |
$503K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,291 |
1,163 |
$498K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,904 |
2,798 |
$493K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,323 |
5,197 |
$415K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,865 |
1,670 |
$383K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,331 |
1,227 |
$367K |
| 93971 |
|
2,348 |
2,217 |
$355K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,640 |
1,167 |
$337K |
| 76830 |
Ultrasound, transvaginal |
3,077 |
2,949 |
$310K |
| 29581 |
|
1,241 |
432 |
$306K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,413 |
1,362 |
$301K |
| 76801 |
|
3,536 |
3,189 |
$293K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,348 |
1,303 |
$254K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,012 |
1,443 |
$248K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,610 |
5,903 |
$227K |
| 71046 |
Radiologic examination, chest; 2 views |
15,534 |
14,561 |
$225K |
| 80053 |
Comprehensive metabolic panel |
42,539 |
34,698 |
$206K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
414 |
387 |
$188K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
298 |
274 |
$175K |
| 97162 |
|
927 |
840 |
$169K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12,040 |
11,177 |
$167K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,309 |
1,217 |
$164K |
| 76641 |
|
729 |
707 |
$148K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,211 |
1,147 |
$132K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,370 |
2,235 |
$122K |
| 73562 |
|
3,679 |
3,281 |
$114K |
| 80320 |
|
5,009 |
4,453 |
$113K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
20,315 |
15,206 |
$109K |
| 97163 |
|
677 |
649 |
$103K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
868 |
822 |
$101K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,489 |
2,261 |
$99K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
392 |
261 |
$96K |
| 70486 |
|
1,914 |
1,810 |
$85K |
| 73630 |
|
3,995 |
3,659 |
$80K |
| 83880 |
|
8,715 |
7,880 |
$74K |
| 76770 |
|
422 |
401 |
$71K |
| 99215 |
Prolong outpt/office vis |
403 |
336 |
$67K |
| 87641 |
|
6,658 |
5,748 |
$62K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
345 |
318 |
$61K |
| 73030 |
|
3,404 |
3,136 |
$61K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
99 |
97 |
$57K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
205 |
201 |
$56K |
| 72110 |
|
1,095 |
1,069 |
$55K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,541 |
741 |
$54K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,624 |
24,957 |
$53K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
73 |
65 |
$49K |
| 76937 |
|
1,302 |
1,111 |
$49K |
| 93970 |
|
253 |
232 |
$46K |
| 97165 |
|
310 |
283 |
$46K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
229 |
161 |
$45K |
| 73130 |
|
4,188 |
3,805 |
$43K |
| 73610 |
|
3,262 |
3,019 |
$42K |
| 71250 |
|
526 |
495 |
$42K |
| 84484 |
|
21,433 |
17,635 |
$40K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
53,216 |
42,889 |
$39K |
| 70496 |
|
56 |
53 |
$34K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,372 |
5,008 |
$34K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
60 |
57 |
$33K |
| 97116 |
|
400 |
295 |
$33K |
| 97166 |
|
119 |
111 |
$33K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
149 |
146 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
12,483 |
11,100 |
$31K |
| 80047 |
|
3,942 |
3,635 |
$30K |
| 87040 |
|
2,589 |
2,287 |
$29K |
| 73502 |
|
1,366 |
1,299 |
$27K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
206 |
190 |
$26K |
| 97161 |
|
94 |
88 |
$22K |
| 73110 |
|
1,884 |
1,737 |
$22K |
| 72100 |
|
889 |
857 |
$21K |
| 84703 |
|
33,477 |
29,741 |
$21K |
| 97535 |
Self-care/home management training, each 15 minutes |
99 |
75 |
$20K |
| 85378 |
|
3,623 |
3,367 |
$20K |
| 84702 |
|
4,360 |
3,918 |
$19K |
| 80329 |
|
961 |
589 |
$18K |
| 83605 |
|
9,155 |
7,714 |
$18K |
| 90715 |
|
670 |
643 |
$18K |
| 86803 |
|
3,506 |
3,269 |
$16K |
| 81001 |
|
40,773 |
36,731 |
$15K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
26 |
26 |
$14K |
| 73564 |
|
1,532 |
1,427 |
$14K |
| 87070 |
|
4,294 |
3,915 |
$13K |
| 72131 |
|
148 |
137 |
$12K |
| 86922 |
|
173 |
150 |
$11K |
| 83735 |
|
16,325 |
10,306 |
$10K |
| 97016 |
|
50 |
49 |
$10K |
| 82947 |
|
19,887 |
11,782 |
$10K |
| 76536 |
|
68 |
68 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
42 |
41 |
$10K |
| 36000 |
|
1,113 |
943 |
$10K |
| 0011A |
|
574 |
522 |
$9K |
| 85027 |
|
5,908 |
3,607 |
$9K |
| 76870 |
|
71 |
68 |
$9K |
| 97012 |
|
37 |
16 |
$9K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
1,882 |
1,721 |
$8K |
| 73080 |
|
772 |
725 |
$8K |
| 77066 |
Tomosynthesis, mammo |
94 |
93 |
$7K |
| 93975 |
|
93 |
89 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,282 |
10,441 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,389 |
1,278 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,420 |
3,088 |
$7K |
| 88141 |
|
250 |
248 |
$7K |
| 94060 |
|
212 |
197 |
$6K |
| 72052 |
|
118 |
116 |
$6K |
| 73590 |
|
860 |
773 |
$6K |
| 87522 |
Neg quan hep c or qual rna |
367 |
335 |
$6K |
| 82552 |
|
4,531 |
3,927 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
951 |
862 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,979 |
2,623 |
$5K |
| 80076 |
|
1,842 |
1,670 |
$4K |
| 99406 |
|
145 |
142 |
$4K |
| 80061 |
Lipid panel |
1,305 |
1,185 |
$4K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
132 |
65 |
$4K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
134 |
129 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,737 |
4,339 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,416 |
4,097 |
$4K |
| 72040 |
|
107 |
106 |
$4K |
| 83690 |
|
14,783 |
12,925 |
$4K |
| 86850 |
|
4,269 |
3,874 |
$3K |
| 73140 |
|
184 |
177 |
$3K |
| 97597 |
|
38 |
26 |
$3K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
124 |
116 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
26 |
24 |
$3K |
| 72070 |
|
82 |
78 |
$3K |
| 84436 |
|
3,214 |
2,899 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,083 |
950 |
$3K |
| 84100 |
|
6,120 |
3,749 |
$3K |
| 70491 |
|
29 |
26 |
$2K |
| 82962 |
|
2,185 |
1,392 |
$2K |
| 87210 |
|
4,390 |
4,118 |
$2K |
| 99386 |
|
13 |
13 |
$2K |
| 82550 |
|
5,480 |
4,723 |
$2K |
| 94010 |
|
102 |
95 |
$2K |
| 85014 |
|
3,961 |
3,585 |
$2K |
| 87186 |
|
2,879 |
2,569 |
$2K |
| 73090 |
|
375 |
352 |
$2K |
| 76642 |
|
14 |
14 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
917 |
883 |
$2K |
| 76775 |
|
12 |
12 |
$2K |
| 87275 |
|
6,192 |
5,748 |
$2K |
| 85610 |
|
7,137 |
6,253 |
$2K |
| 76942 |
|
108 |
97 |
$2K |
| 90686 |
|
119 |
117 |
$2K |
| 0004A |
|
34 |
27 |
$2K |
| 86901 |
|
4,261 |
3,876 |
$2K |
| 73620 |
|
98 |
94 |
$1K |
| 76000 |
|
481 |
433 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
989 |
918 |
$1K |
| 86900 |
|
4,263 |
3,877 |
$1K |
| 73552 |
|
156 |
135 |
$1K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
2,273 |
2,114 |
$1K |
| 74018 |
|
52 |
50 |
$983.42 |
| 87276 |
|
6,191 |
5,747 |
$936.47 |
| 87088 |
|
2,519 |
2,326 |
$935.65 |
| 85730 |
|
7,046 |
6,174 |
$928.21 |
| 94727 |
|
69 |
58 |
$849.12 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,527 |
3,334 |
$831.73 |
| 84479 |
|
3,175 |
2,865 |
$825.03 |
| 82803 |
|
844 |
696 |
$728.22 |
| 71101 |
|
200 |
189 |
$674.95 |
| 87077 |
|
2,241 |
1,990 |
$603.51 |
| 77065 |
Tomosynthesis, mammo |
15 |
15 |
$583.71 |
| 86141 |
|
859 |
774 |
$561.15 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
41 |
39 |
$537.44 |
| 80050 |
General health panel |
46 |
41 |
$520.32 |
| 73560 |
|
28 |
24 |
$489.11 |
| 82010 |
|
1,172 |
1,037 |
$437.69 |
| 97164 |
|
25 |
25 |
$431.59 |
| 36600 |
|
236 |
199 |
$413.62 |
| 85652 |
|
927 |
830 |
$348.52 |
| 72170 |
|
44 |
42 |
$344.71 |
| 74022 |
|
44 |
44 |
$323.73 |
| 80352 |
|
258 |
225 |
$317.80 |
| 80074 |
|
28 |
27 |
$311.90 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
44 |
43 |
$267.48 |
| 86592 |
|
151 |
145 |
$253.10 |
| 80185 |
|
27 |
24 |
$230.44 |
| 82728 |
|
100 |
90 |
$216.77 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
159 |
142 |
$210.05 |
| 87340 |
|
492 |
399 |
$203.57 |
| 87535 |
|
39 |
37 |
$199.16 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
749 |
703 |
$194.25 |
| 84550 |
|
76 |
72 |
$176.37 |
| 83718 |
|
13 |
13 |
$169.91 |
| 73521 |
|
12 |
12 |
$157.99 |
| 82553 |
|
65 |
41 |
$144.79 |
| 73060 |
|
70 |
68 |
$140.12 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
68 |
67 |
$134.19 |
| 73660 |
|
12 |
12 |
$126.70 |
| 86703 |
|
167 |
162 |
$123.16 |
| 83520 |
|
174 |
153 |
$110.91 |
| 84153 |
|
35 |
34 |
$107.81 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
599 |
561 |
$103.36 |
| 80143 |
|
792 |
700 |
$101.36 |
| 88312 |
|
170 |
153 |
$98.74 |
| 84439 |
|
16 |
14 |
$96.15 |
| 82465 |
|
14 |
14 |
$80.50 |
| 82150 |
|
265 |
228 |
$76.66 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
806 |
696 |
$75.24 |
| 81003 |
|
429 |
379 |
$70.63 |
| A4618 |
Breathing circuits |
458 |
344 |
$61.54 |
| G0008 |
Administration of influenza virus vaccine |
73 |
72 |
$54.80 |
| 80179 |
|
753 |
676 |
$50.67 |
| 85044 |
|
96 |
69 |
$40.32 |
| 99001 |
|
179 |
174 |
$39.20 |
| 83550 |
|
43 |
37 |
$35.99 |
| 81025 |
|
287 |
263 |
$35.94 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
575 |
502 |
$29.92 |
| 81002 |
|
224 |
208 |
$29.87 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,495 |
3,502 |
$24.73 |
| A7521 |
Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each |
437 |
330 |
$21.08 |
| 84600 |
|
113 |
83 |
$11.64 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,432 |
968 |
$6.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,208 |
2,867 |
$6.07 |
| J3490 |
Unclassified drugs |
659 |
452 |
$5.95 |
| 94761 |
|
90 |
80 |
$5.87 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,180 |
1,743 |
$5.62 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
239 |
197 |
$2.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,618 |
1,400 |
$1.15 |
| J2060 |
Injection, lorazepam, 2 mg |
416 |
337 |
$0.48 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,165 |
995 |
$0.46 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
281 |
229 |
$0.23 |
| C9113 |
Injection, pantoprazole sodium, per vial |
216 |
130 |
$0.22 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
262 |
182 |
$0.04 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
252 |
242 |
$0.00 |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
503 |
272 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
914 |
323 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
468 |
348 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
291 |
273 |
$0.00 |
| 0272 |
|
288 |
220 |
$0.00 |
| A6457 |
Tubular dressing with or without elastic, any width, per linear yard |
1,095 |
412 |
$0.00 |
| A6219 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
195 |
120 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
45 |
31 |
$0.00 |
| A4730 |
Fistula cannulation set for hemodialysis, each |
61 |
26 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
53 |
25 |
$0.00 |
| A6220 |
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
27 |
15 |
$0.00 |
| 94664 |
|
72 |
61 |
$0.00 |
| A6209 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
18 |
13 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
28 |
16 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
62 |
46 |
$0.00 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
82 |
64 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
158 |
88 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
106 |
52 |
$0.00 |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
1,439 |
612 |
$0.00 |
| 96376 |
|
68 |
67 |
$0.00 |
| A6441 |
Padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard |
252 |
99 |
$0.00 |
| 0270 |
|
121 |
72 |
$0.00 |
| 99000 |
|
101 |
91 |
$0.00 |
| 0250 |
|
6,970 |
2,207 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
185 |
161 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
274 |
173 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
62 |
58 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
41 |
31 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
282 |
211 |
$0.00 |
| 0271 |
|
63 |
54 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
14 |
14 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
77 |
64 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
257 |
153 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
26 |
26 |
$0.00 |
| 0258 |
|
18 |
13 |
$0.00 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
14 |
12 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
20 |
13 |
$0.00 |
| 88304 |
|
16 |
13 |
$0.00 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
16 |
13 |
$0.00 |